Geneticum and Proventia

By Ubbat Ocak in 2019 Posted January 5, 2019

MUB Medical Granted Funding & Joins Proventia Incubator Program to Drive Growth and Innovation!

We are delighted to announce that MUB Medical Solutions has successfully secured funding from two esteemed organizations, Stiftelsen Geneticum and Proventia. This financial support marks a significant milestone in our journey to bring Sutrips to the forefront of the wound closure industry.

The funding received from Stiftelsen Geneticum and Proventia will play a vital role in our mission to advance the regulatory pathway for Sutrips. With this financial backing, we will initiate a comprehensive study to navigate the regulatory landscape and ensure compliance with industry standards and requirements. This important step brings us closer to achieving the necessary certifications and approvals needed to bring Sutrips to market.

“We are incredibly grateful for the generous funding provided by Stiftelsen Geneticum and Proventia,” says Ubbat Ocak, Founder of MUB Medical Solutions. “Their support is a testament to their belief in our vision and the potential impact of Sutrips in revolutionizing wound closure. With this funding, we can accelerate our efforts to navigate the regulatory pathway and ensure that Sutrips meets all necessary regulatory standards.”

By securing these funds, we can dedicate resources to conduct in-depth research, collaborate with regulatory experts, and streamline the process of obtaining regulatory approvals. This study will provide us with valuable insights and enable us to develop a robust regulatory strategy that ensures the safety, efficacy, and compliance of Sutrips.

Yasar Shaikh, CEO of MUB Medical Solutions, emphasizes the significance of this funding in propelling our mission forward. “The funding from Stiftelsen Geneticum and Proventia is a game-changer for us. It enables us to take concrete steps towards fulfilling regulatory requirements and ultimately bringing Sutrips to the hands of healthcare professionals and patients who can benefit from its innovative wound closure capabilities.”

We extend our deepest gratitude to Stiftelsen Geneticum and Proventia for their trust and support in our vision. Their funding enables us to forge ahead in our mission to improve wound closure practices and provide healthcare professionals with a revolutionary solution.

Stay tuned for more updates as we progress through the regulatory pathway and work towards making Sutrips a reality. Follow us on our social media platforms and website to stay informed about our latest developments and milestones.

Explore Klosteroya Fondet and Proventia.

Klosterøya Fondet and Proventia

By Ubbat Ocak in 2018 Posted December 5, 2018

MUB Medical Receives Development Loan and Joins Proventia Preincubation Program

MUB Medical is thrilled to announce two major milestones that will propel us forward in our mission to transform the wound closure industry. We have been offered a development loan by Klosterøya Fondet, a testament to our potential for growth and innovation. Additionally, we are excited to share that we have joined the renowned Proventia preincubation program, further strengthening our position in the entrepreneurial ecosystem.

Founder Ubbat Ocak expresses his enthusiasm, stating, “The development loan from Klosterøya Fondet is a significant milestone for MUB Medical. It will provide us with the financial resources needed to accelerate the development of our revolutionary wound closure solutions. We are grateful for the support and trust shown by Klosterøya Fondet in our vision and look forward to delivering innovative products that will make a positive impact.”

CEO Yasar Shaikh adds, “Joining the Proventia preincubation program marks a crucial step in our growth journey. Incubation has proven to be an effective method for nurturing and realizing new business ideas, and we are excited to collaborate with Proventia’s experienced team. Their support in terms of services, infrastructure, networks, and investor connections will be instrumental in shaping our path to success.”

Proventia, established in 2013, is renowned for its dedication to helping entrepreneurs and visionaries commercialize unique business ideas with regional potential. Their focus on supporting and guiding founders aligns perfectly with MUB Medical’s goals. Through this program, we will have access to valuable resources, expertise, and networks that will enable us to refine our business model and maximize our potential for success.

“Proventia’s commitment to developing sound business ideas into profitable ventures resonates with our vision at MUB Medical,” states Yasar Shaikh. “We appreciate their dedication to our success and their role in fostering sustainable growth in the region. Together, we will navigate the entrepreneurial journey, with a shared goal of realizing dreams and creating innovative solutions.”

As we embark on this exciting chapter, we extend our gratitude to Klosterøya Fondet and Proventia for their belief in our vision and their support in our journey to revolutionize the wound closure industry. These partnerships will strengthen our ability to invest in research, development, and analyzing the patent landscape, further solidifying our position as a key player in the healthcare sector.

Stay connected with MUB Medical on our LinkedIn page for updates on our progress, new developments, and exciting milestones. We are committed to advancing wound closure solutions and driving positive change in the industry.

Funding From Innovation Norway

By Ubbat Ocak in 2018 Posted April 29, 2018

MUB Medical Secures Funding from Innovation Norway

MUB Medical, a pioneering medical device company, is thrilled to announce that it has been granted funding from Innovation Norway, Commercialization Phase 1, the Norwegian Government’s leading catalyst for innovation and enterprise development. This funding marks a significant milestone in MUB Medical’s journey towards revolutionizing wound closure solutions with its groundbreaking product, Sutrips.

Innovation Norway plays a vital role in supporting and promoting the growth of Norwegian businesses by fostering innovation and enhancing their competitive advantage. With their comprehensive range of programs and services, Innovation Norway empowers entrepreneurs, facilitates the development of high-growth enterprises, and fosters collaborative innovation ecosystems.

The funding received from Innovation Norway will provide MUB Medical with valuable resources to further invest in the development of Sutrips. This includes conducting in-depth analysis of the patent landscape to ensure the product’s uniqueness and competitive edge. By leveraging this funding, MUB Medical aims to accelerate its research and development efforts, enhancing the functionality and effectiveness of Sutrips to meet the evolving needs of healthcare professionals.

“We are delighted to receive this funding support from Innovation Norway,” said Ubbat Ocak, Founder of MUB Medical. “This investment will enable us to strengthen our commitment to innovation and propel our mission of revolutionizing wound closure solutions. With the backing of Innovation Norway, we are confident in our ability to deliver cutting-edge products that improve patient outcomes and transform the healthcare industry.”

“MUB Medical is dedicated to developing advanced medical devices that simplify and optimize wound closure procedures, ultimately improving the quality of care for patients” said Yasar Shaikh, CEO of MUB Medical. “The funding received from Innovation Norway will not only fuel the development of Sutrips but also bolster MUB Medical’s position as an innovator in the field of wound closure technology”.

About MUB Medical:

MUB Medical is a progressive medical device company focused on revolutionizing wound closure solutions. With a commitment to innovation and simplicity, MUB Medical aims to empower healthcare professionals with advanced tools that enhance patient care and outcomes. Their flagship product, Sutrips, represents a paradigm shift in wound closure, offering efficient, reliable, and user-friendly solutions for medical practitioners.

For more information about MUB Medical and its innovative products, please visit www.mubmedical.com and follow LinkedIn page for exciting updates www.linkedin.com/company/mub-medical-solutions-as/

About Innovation Norway:

Innovation Norway is the Norwegian Government’s foremost instrument for innovation and development of Norwegian enterprises and industry. Through its comprehensive range of programs and services, Innovation Norway supports businesses in developing their competitive advantage and fostering innovation across various sectors of the Norwegian economy. By stimulating profitable business development and encouraging collaboration, Innovation Norway plays a vital role in driving economic growth and sustainable development in Norway.